What is the current stock price of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)?

As of the latest market data, Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is trading at $10.52. The stock has seen a loss of -0.02% today.

Does Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) pay a dividend?

Based on current data, Drugs Made In America Acquisition Corp. Ordinary Shares does not have a confirmed active dividend policy.

DMAA

Q: What is the market cap of Drugs Made In America Acquisition Corp. Ordinary Shares?

The current market capitalization of Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is approximately unavailable.

Drugs Made In America Acquisition Corp. Ordinary Shares·Financial Services

10.52

0.023%(−0.00)

Market Closed

12.88

22.461%(+2.36)

After Hours

Last Updated: — ET

52W L: $10.0252W H: $10.52

DMAA NEWS

defenseworld.net

Mar 9

Drugs Made In America Acquisition Corp. $DMAA Shares Sold by DLD Asset Management LP

DLD Asset Management LP reduced its stake in Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) by 39.8% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 113,672 shares of the company's stock after selling 75,050 shares during the period.

Company Profile

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Sector

Financial Services

Industry

Shell Companies

Employees

IPO Date

2025-01-27

Beta

-0.00

Websitedmaacorp.com↗